Home  >  Products  >  CCT2 (chaperonin containing TCP1, subunit 2 (beta) ) Blocking Peptide (the middle region of CCT2)(100ug)
CCT2 (chaperonin containing TCP1, subunit 2 (beta) ) Blocking Peptide (the middle region of CCT2)(100ug)

CCT2 (chaperonin containing TCP1, subunit 2 (beta) ) Blocking Peptide (the middle region of CCT2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TAZ Antibody (ARP63399_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP63399
Size: 100ug
Weight: 28kDa
Gene: 6901
Format: Lyophilized powder
Target: This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
Alternative names: BTHS; CMD3A; EFE; EFE2; FLJ27390; G4.5; LVNCX; Taz1; XAP-2
See Full Product Listings >